About Us
Our Story
Committed to Excellence
At Suburban Neurology, we are dedicated to providing exceptional neurological care with expertise, compassion, and innovation. Led by Dr. Misra, a highly experienced neurologist with over 20 years of practice, our clinic specializes in diagnosing and treating a wide range of neurological conditions, including migraines, epilepsy, stroke, Parkinson’s disease, multiple sclerosis, and neuropathy.
Our mission is to enhance the quality of life for our patients through advanced diagnostic techniques, personalized treatment plans through latest medical advancements. We believe in a patient-centered approach, ensuring each individual receives comprehensive care tailored to their unique needs.
With state-of-the-art facilities and a commitment to excellence, Suburban Neurology is your trusted partner in neurological health. Whether you need expert consultation, long-term management, or cutting-edge therapies, we are here to support you every step of the way.
Our Values
Our Work Is Heavily Shaped by Our Core Values
01.
Compassionate Care
We prioritize patient well-being by providing empathetic, personalized, and respectful care to everyone we serve.
02.
Excellence & Expertise
We are committed to delivering the highest standard of neurological care through continuous learning, advanced diagnostics, and innovative treatments.
03.
Patient-Centered Approach
We believe in empowering patients with knowledge, involving them in their treatment decisions, and tailoring care to their unique needs.
04.
Integrity & Trust
We uphold the highest ethical standards, ensuring transparency, honesty, and trust in every aspect of patient care and treatment.
News Blog
Latest Neurological Advancement
- Migraine Treatment Zavegepant Shows No Meaningful Impact on Oral Contraceptive Exposure
- A Clinician’s Perspective on First-in-Human Data for LRRK2 Degrader ARV-102
- Large Danish Cohort Study Reveals No Significant Association Between HLA Alleles and Migraine
- Recognizing and Managing Paraneoplastic Neurological Syndromes: Ditte Primdahl, MD; Shailee Samir Shah, MD
- Afterimage Duration Significantly Longer in Migraine With Aura Than Without
- FDA Expands Diazepam Nasal Spray Indication to Treat Ages 2 to 5
- Adapting Cognitive Tools for Clinical Trials in Down Syndrome: Elizabeth Head, PhD
- NeuroVoices: Beth Stein, MD, on Implications of Newly Approved Pre-Filled Syringe Option for Efgartigimod
- Highlighting Early-Stage Promising Data of AAK1 Inhibitor SAT-3247 in Duchenne Muscular Dystrophy: Phil Lambert, PhD
- FDA Approves CT-132 as First Digital Therapeutic for Preventive Treatment of Episodic Migraine
- Advancements and Challenges in Pediatric Multiple Sclerosis Treatment: Lauren B. Krupp, MD
- Investigational Telitacicept Significantly Improves Myasthenia Gravis Outcomes in Phase 3 Study
- Del-Zota Produced Statistically Significant Increases in Exon-Skipping and Dystrophin Levels in EXPLORE44, a Phase 1/2 Study in Individuals With DMD44M
- Harnessing Gamma Frequencies to Modulate Alzheimer Pathology: Ralph Kern, MD, MHSc
- Phase 2 RESCUE Data Show RNS60 Reduces Stroke Infarct and Improves Outcomes
- Promising New Data on Stem Cell Therapy for PD
- Anticonvulsant Cuts Pain Fast in Facial Neuralgia
- Cerebral Protection in TAVI: A Picture vs Data
- Social Media Fuels Dubious Cortisol Craze
- After 25 Years of Effort, Is Stroke Care Meeting the Need?
- Does Thrombolysis Affect Outcomes in Tandem Lesion Stroke?
- UK Study Tracks Variant CJD in Children Over 27 Years
- Repurposed Antidepressant Effective for Narcolepsy
- AAN 2025: Key Updates on Diagnosis, Safety, and Diet in RRMS
- Novel Agent Shows Promise in Early Parkinson’s Disease
- EU Authorizes Leqembi for Early Alzheimer's Treatment
- AAN 2025: Key Highlights of Advances in Myasthenia Gravis
- Cervical Artery Dissection Cases Surge in the United States
- Poor Oral Health Linked to Migraine, Chronic Pain in Women
- BP in Early Pregnancy Predicts Future Hypertension Risk